The Empire Ball is one of the most highly anticipated events in New York City for the real estate and construction industries. Each year, these industries come together to pay homage to its esteemed colleagues, while raising critical funds for the Diabetes Research Institute (DRI) and their work to find a biological cure.
We promise to uphold our annual tradition of delivering an engaging, informative, and uplifting program that showcases the work of the Diabetes Research Institute (DRI), all while having a great time!
Program:
5:45 PM - 6:15 PM
Cocktail Lounge Sponsored by Tito's Handmade Vodka (You must be Age 21 or older to enter this lounge)
Networking Lounges Open
6:15 PM - 7:15 PM
Main Stage Empire Ball 2020 goes live!
7:15 PM - 8:00 PM
After Party
Virtual networking continues!
Your support—through both your engagement and your philanthropic generosity—is important, meaningful, and deeply appreciated.
Diabetes doesn’t take a break, and neither can we.
Hosted By:
Co-anchor CBS 2 News This Morning and CBS 2 News At Noon
Light the Sky for DRI
As a part of our celebration, prominent venues and landmarks in New York City and beyond, will light their properties blue; shining a light on this insidious disease and the critical work that the Diabetes Research Institute is doing to find a biological cure now.
Confirmed Lighting Partners*:
The AT&T Discovery District Canada Lands Company
| New York State Thruway Authority
|
* in formation
About the Diabetes Research Institute Foundation (DRIF) & Diabetes Research Institute (DRI)
The Diabetes Research Institute Foundation is the organization of choice for those who are serious, passionate and committed to curing diabetes. Its mission – to provide the Diabetes Research Institute with the funding necessary to cure diabetes now – is a testament to the belief that tomorrow is not soon enough to cure those living with diabetes.
The Diabetes Research Institute leads the world in cure-focused diabetes research. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure for diabetes by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. The DRI continues to develop its BioHub strategy, a multidisciplinary, three-pronged approach for addressing the major challenges that stand in the way of a cure: eliminate the need for anti-rejection drugs, reset the immune system to block autoimmunity, and develop an unlimited supply of insulin-producing cells.